ChitomedP.S.A.

Manufacture of other medical instruments and supplies

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-01-31
Activity description

Chitomed is a company that develops and implements technological solutions based on biomaterials, specializing in chitosan and microcrystalline chitosan for the pharmaceutical, medical, and cosmetics industries. They are involved in 3D bioprinting solutions, advanced regenerative dermocosmetics, and multifunctional bio-hydrogel systems for various medical applications. Their products include medical devices and drug carriers, emphasizing high purity and low production costs.

Registered address
ul. Jana Henryka Dąbrowskiego 77/A, 60-529 Poznań, Poland
Website
chitomed.comWebsite active
Email
Email address current
Social media
Electronic delivery address
AE:PL-24878-77138-JFBDE-23

Financials

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 206.59kMedianUSD 848.96kAverageUSD 8.35m
Net profit
This companyUSD -48.67kMedianUSD 20.21kAverageUSD 574.87k
Operating costs
This companyUSD 254.33kMedianUSD 663.86kAverageUSD 7.41m
Assets
This companyUSD 6.02mMedianUSD 974.48kAverageUSD 6.92m

Industry

Bank accounts

Registered as a VAT taxpayer on 2025-03-22. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$7,388

Tenders

No recorded participation in tenders.

Authorized Representatives

Edyta Wątrobińska — President of the Management Board

Manner of representation

If the management board consists of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Beneficial owners

Person
Edyta Wątrobińska (43)

Competitors

Name
Implaisp. z o.o.
Medical InventiS.A.
UnitedmedP.S.A.
Smart Labssp. z o.o.
Imperio Laboratoriessp. z o.o.

FAQ

Last updated: 2026-07-12